{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:05:50Z","timestamp":1789387550049,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"DOI":"10.7759\/cureus.116210","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:30:51Z","timestamp":1789385451000},"source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Assisted Reproduction Technology on Breast Cancer Risk for Women With Infertility: Current Insights and Future Perspectives"],"prefix":"10.7759","author":[{"given":"Kanelina","family":"Bimpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil M","family":"Xydias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Varvaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios N","family":"Koronarchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Tsakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto AN","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, et al.. Breast cancer statistics 2024. CA Cancer J Clin. 2024, 74:477-95. 10.3322\/caac.21863","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.105357","article-title":"Conception and concern: a review of breast cancer risk in assisted reproductive technology","volume":"21","author":"Guo Z","year":"2025","unstructured":"Guo Z, Zhu Z, Lin X, et al.. Conception and concern: a review of breast cancer risk in assisted reproductive technology. Int J Biol Sci. 2025, 21:2647-71. 10.7150\/ijbs.105357","journal-title":"Int J Biol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro RS","year":"2014","unstructured":"Legro RS, Brzyski RG, Diamond MP, et al.. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014, 371:119-29. 10.1056\/NEJMoa1313517","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010287.pub4","article-title":"Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome","volume":"9","author":"Franik S","year":"2022","unstructured":"Franik S, Le QK, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2022, 9:CD010287. 10.1002\/14651858.CD010287.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-200301000-00004","article-title":"The possible association between in vitro fertilization treatments and cancer development","volume":"13","author":"Lerner-Geva L","year":"2003","unstructured":"Lerner-Geva L, Geva E, Lessing JB, Chetrit A, Modan B, Amit A. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer. 2003, 13:23-7. 10.1136\/ijgc-00009577-200301000-00004","journal-title":"Int J Gynecol Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)04950-6","article-title":"Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study","volume":"79","author":"Burkman RT","year":"2003","unstructured":"Burkman RT, Tang MT, Malone KE, et al.. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril. 2003, 79:844-51. 10.1016\/s0015-0282(02)04950-6","journal-title":"Fertil Steril"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh422","article-title":"Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study","volume":"19","author":"Gauthier E","year":"2004","unstructured":"Gauthier E, Paoletti X, Clavel-Chapelon F. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod. 2004, 19:2216-21. 10.1093\/humrep\/deh422","journal-title":"Hum Reprod"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh371","article-title":"Breast cancer risk associated with ovulation-stimulating drugs","volume":"19","author":"Brinton LA","year":"2004","unstructured":"Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Althuis MD, Mabie JE, Lamb EJ. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod. 2004, 19:2005-13. 10.1093\/humrep\/deh371","journal-title":"Hum Reprod"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9238-4","article-title":"Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women","volume":"100","author":"Lerner-Geva L","year":"2006","unstructured":"Lerner-Geva L, Keinan-Boker L, Blumstein T, et al.. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women. Breast Cancer Res Treat. 2006, 100:201-12. 10.1007\/s10549-006-9238-4","journal-title":"Breast Cancer Res Treat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del411","article-title":"Tumour incidence in Swedish women who gave birth following IVF treatment","volume":"22","author":"Kristiansson P","year":"2007","unstructured":"Kristiansson P, Bj\u00f6r O, Wramsby H. Tumour incidence in Swedish women who gave birth following IVF treatment. Hum Reprod. 2007, 22:421-6. 10.1093\/humrep\/del411","journal-title":"Hum Reprod"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0075","article-title":"Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study","volume":"16","author":"Jensen A","year":"2007","unstructured":"Jensen A, Sharif H, Svare EI, Frederiksen K, Kjaer SK. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarkers Prev. 2007, 16:1400-7. 10.1158\/1055-9965.EPI-07-0075","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9800-2","article-title":"The possible association between IVF and breast cancer incidence","volume":"15","author":"Pappo I","year":"2008","unstructured":"Pappo I, Lerner-Geva L, Halevy A, et al.. The possible association between IVF and breast cancer incidence. Ann Surg Oncol. 2008, 15:1048-55. 10.1245\/s10434-007-9800-2","journal-title":"Ann Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605086","article-title":"Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort","volume":"100","author":"Silva Idos S","year":"2009","unstructured":"Silva Idos S, Wark PA, McCormack VA, et al.. Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer. 2009, 100:1824-31. 10.1038\/sj.bjc.6605086","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn318","article-title":"Cancer risk after exposure to treatments for ovulation induction","volume":"169","author":"Calderon-Margalit R","year":"2009","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R, et al.. Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol. 2009, 169:365-75. 10.1093\/aje\/kwn318","journal-title":"Am J Epidemiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.08.066","article-title":"Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study","volume":"200","author":"Org\u00e9as CC","year":"2009","unstructured":"Org\u00e9as CC, Sanner K, Hall P, et al.. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study. Am J Obstet Gynecol. 2009, 200:72.e1-7. 10.1016\/j.ajog.2008.08.066","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq307","article-title":"Malignancies among women who gave birth after in vitro fertilization","volume":"26","author":"K\u00e4ll\u00e9n B","year":"2011","unstructured":"K\u00e4ll\u00e9n B, Finnstr\u00f6m O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod. 2011, 26:253-8. 10.1093\/humrep\/deq307","journal-title":"Hum Reprod"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.671391","article-title":"Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up","volume":"28","author":"Lerner-Geva L","year":"2012","unstructured":"Lerner-Geva L, Rabinovici J, Olmer L, Blumstein T, Mashiach S, Lunenfeld B. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecol Endocrinol. 2012, 28:809-14. 10.3109\/09513590.2012.671391","journal-title":"Gynecol Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.04.019","article-title":"In\u00a0vitro fertilization and breast cancer: is there cause for concern?","volume":"98","author":"Stewart LM","year":"2012","unstructured":"Stewart LM, Holman CD, Hart R, Bulsara MK, Preen DB, Finn JC. In\u00a0vitro fertilization and breast cancer: is there cause for concern?. Fertil Steril. 2012, 98:334-40. 10.1016\/j.fertnstert.2012.04.019","journal-title":"Fertil Steril"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des031","article-title":"Cancer morbidity in a cohort of 9175 Finnish women treated for infertility","volume":"27","author":"Yli-Kuha AN","year":"2012","unstructured":"Yli-Kuha AN, Gissler M, Klemetti R, Luoto R, Hemminki E. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod. 2012, 27:1149-55. 10.1093\/humrep\/des031","journal-title":"Hum Reprod"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs255","article-title":"Fertility drugs and young-onset breast cancer: results from the Two Sister Study","volume":"104","author":"Fei C","year":"2012","unstructured":"Fei C, Deroo LA, Sandler DP, Weinberg CR. Fertility drugs and young-onset breast cancer: results from the Two Sister Study. J Natl Cancer Inst. 2012, 104:1021-7. 10.1093\/jnci\/djs255","journal-title":"J Natl Cancer Inst"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.12.029","article-title":"In\u00a0vitro fertilization and risk of breast\u00a0and gynecologic cancers: a retrospective cohort study within\u00a0the Israeli Maccabi Healthcare Services","volume":"99","author":"Brinton LA","year":"2013","unstructured":"Brinton LA, Trabert B, Shalev V, Lunenfeld E, Sella T, Chodick G. In\u00a0vitro fertilization and risk of breast\u00a0and gynecologic cancers: a retrospective cohort study within\u00a0the Israeli Maccabi Healthcare Services. Fertil Steril. 2013, 99:1189-96. 10.1016\/j.fertnstert.2012.12.029","journal-title":"Fertil Steril"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-0996","article-title":"Long-term relationship of ovulation-stimulating drugs to breast cancer risk","volume":"23","author":"Brinton LA","year":"2014","unstructured":"Brinton LA, Scoccia B, Moghissi KS, et al.. Long-term relationship of ovulation-stimulating drugs to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2014, 23:584-93. 10.1158\/1055-9965.EPI-13-0996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29069","article-title":"Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway","volume":"136","author":"Reigstad MM","year":"2015","unstructured":"Reigstad MM, Larsen IK, Myklebust T\u00c5, et al.. Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway. Int J Cancer. 2015, 136:1140-8. 10.1002\/ijc.29069","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.07.1135","article-title":"Cancer in women after assisted reproductive technology","volume":"104","author":"Luke B","year":"2015","unstructured":"Luke B, Brown MB, Spector LG, et al.. Cancer in women after assisted reproductive technology. Fertil Steril. 2015, 104:1218-26. 10.1016\/j.fertnstert.2015.07.1135","journal-title":"Fertil Steril"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-2035-x","article-title":"The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up","volume":"142","author":"Kessous R","year":"2016","unstructured":"Kessous R, Davidson E, Meirovitz M, Sergienko R, Sheiner E. The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. J Cancer Res Clin Oncol. 2016, 142:287-93. 10.1007\/s00432-015-2035-x","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.9389","article-title":"Ovarian stimulation for in vitro fertilization and long-term risk of breast cancer","volume":"316","author":"van den Belt-Dusebout AW","year":"2016","unstructured":"van den Belt-Dusebout AW, Spaan M, Lambalk CB, et al.. Ovarian stimulation for in vitro fertilization and long-term risk of breast cancer. JAMA. 2016, 316:300-12. 10.1001\/jama.2016.9389","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0809","article-title":"Cancer risk in women treated with fertility drugs according to parity status-a registry-based cohort study","volume":"26","author":"Reigstad MM","year":"2017","unstructured":"Reigstad MM, Storeng R, Myklebust T\u00c5, et al.. Cancer risk in women treated with fertility drugs according to parity status-a registry-based cohort study. Cancer Epidemiol Biomarkers Prev. 2017, 26:953-62. 10.1158\/1055-9965.EPI-16-0809","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.05.010","article-title":"Ovarian stimulation and risk of breast cancer in Swedish women","volume":"108","author":"Lundberg FE","year":"2017","unstructured":"Lundberg FE, Iliadou AN, Rodriguez-Wallberg K, Bergh C, Gemzell-Danielsson K, Johansson AL. Ovarian stimulation and risk of breast cancer in Swedish women. Fertil Steril. 2017, 108:137-44. 10.1016\/j.fertnstert.2017.05.010","journal-title":"Fertil Steril"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0139-1","article-title":"Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1\/2 mutation carriers","volume":"119","author":"Derks-Smeets IA","year":"2018","unstructured":"Derks-Smeets IA, Schrijver LH, de Die-Smulders CE, et al.. Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1\/2 mutation carriers. Br J Cancer. 2018, 119:357-63. 10.1038\/s41416-018-0139-1","journal-title":"Br J Cancer"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2644","article-title":"Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation","volume":"362","author":"Williams CL","year":"2018","unstructured":"Williams CL, Jones ME, Swerdlow AJ, et al.. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. BMJ. 2018, 362:k2644. 10.1136\/bmj.k2644","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2018.03.003","article-title":"Breast cancer and ovulation induction treatments","volume":"18","author":"Taheripanah R","year":"2018","unstructured":"Taheripanah R, Balash F, Anbiaee R, Mahmoodi M, Akbari Sene A. Breast cancer and ovulation induction treatments. Clin Breast Cancer. 2018, 18:395-9. 10.1016\/j.clbc.2018.03.003","journal-title":"Clin Breast Cancer"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2019.11.015","article-title":"Cancer in IVF patients treated at age 40 years and older: long term follow-up","volume":"40","author":"Tsafrir A","year":"2020","unstructured":"Tsafrir A, Lerner-Geva L, Zaslavsky-Paltiel I, et al.. Cancer in IVF patients treated at age 40 years and older: long term follow-up. Reprod Biomed Online. 2020, 40:369-73. 10.1016\/j.rbmo.2019.11.015","journal-title":"Reprod Biomed Online"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.02.030","article-title":"Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers","volume":"116","author":"Perri T","year":"2021","unstructured":"Perri T, Naor-Revel S, Eliassi-Revivo P, Lifshitz D, Friedman E, Korach J. Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers. Fertil Steril. 2021, 116:538-45. 10.1016\/j.fertnstert.2021.02.030","journal-title":"Fertil Steril"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab219","article-title":"Assisted reproductive technology treatment and risk of breast cancer: a population-based cohort study","volume":"36","author":"Vassard D","year":"2021","unstructured":"Vassard D, Pinborg A, Kamper-J\u00f8rgensen M, Lyng Forman J, Glazer CH, Kroman N, Schmidt L. Assisted reproductive technology treatment and risk of breast cancer: a population-based cohort study. Hum Reprod. 2021, 36:3152-60. 10.1093\/humrep\/deab219","journal-title":"Hum Reprod"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab270","article-title":"Ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study","volume":"37","author":"Machtinger R","year":"2022","unstructured":"Machtinger R, Fallach N, Goldstein I, Chodick G, Schiff E, Orvieto R, Mashiach R. Ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study. Hum Reprod. 2022, 37:577-85. 10.1093\/humrep\/deab270","journal-title":"Hum Reprod"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.01.044","article-title":"Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis","volume":"116","author":"Beebeejaun Y","year":"2021","unstructured":"Beebeejaun Y, Athithan A, Copeland TP, Kamath MS, Sarris I, Sunkara SK. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis. Fertil Steril. 2021, 116:198-207. 10.1016\/j.fertnstert.2021.01.044","journal-title":"Fertil Steril"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrab149","article-title":"Fertility treatment and breast-cancer incidence: meta-analysis","volume":"6","author":"Cullinane C","year":"2022","unstructured":"Cullinane C, Gillan H, Geraghty J, et al.. Fertility treatment and breast-cancer incidence: meta-analysis. BJS Open. 2022, 6:10.1093\/bjsopen\/zrab149","journal-title":"BJS Open"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay K","year":"2005","unstructured":"Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005, 23:4347-53. 10.1200\/JCO.2005.05.037","journal-title":"J Clin Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer","volume":"101","author":"Kim J","year":"2016","unstructured":"Kim J, Turan V, Oktay K. Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab. 2016, 101:1364-71. 10.1210\/jc.2015-3878","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-1140-4","article-title":"Fertility drugs and the risk of breast cancer: a meta-analysis and review","volume":"124","author":"Zreik TG","year":"2010","unstructured":"Zreik TG, Mazloom A, Chen Y, et al.. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat. 2010, 124:13-26. 10.1007\/s10549-010-1140-4","journal-title":"Breast Cancer Res Treat"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050776","article-title":"Estrogen carcinogenesis in breast cancer","volume":"354","author":"Yager JD","year":"2006","unstructured":"Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006, 354:270-82. 10.1056\/NEJMra050776","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-1630","article-title":"DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast","volume":"150","author":"Graham JD","year":"2009","unstructured":"Graham JD, Mote PA, Salagame U, et al.. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 2009, 150:3318-26. 10.1210\/en.2008-1630","journal-title":"Endocrinology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054206","article-title":"Reactive oxygen species via redox signaling to PI3K\/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells","volume":"8","author":"Okoh VO","year":"2013","unstructured":"Okoh VO, Felty Q, Parkash J, Poppiti R, Roy D. Reactive oxygen species via redox signaling to PI3K\/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells. PLoS One. 2013, 8:e54206. 10.1371\/journal.pone.0054206","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-128x(96)00242-5","article-title":"The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site","volume":"62","author":"Anstead GM","year":"1997","unstructured":"Anstead GM, Carlson KE, Katzenellenbogen JA. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids. 1997, 62:268-303. 10.1016\/s0039-128x(96)00242-5","journal-title":"Steroids"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1323","article-title":"Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies","volume":"170","author":"Nichols HB","year":"2019","unstructured":"Nichols HB, Schoemaker MJ, Cai J, et al.. Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med. 2019, 170:22-30. 10.7326\/M18-1323","journal-title":"Ann Intern Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1839","article-title":"Pregnancy-associated breast cancer and metastasis","volume":"6","author":"Schedin P","year":"2006","unstructured":"Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer. 2006, 6:281-91. 10.1038\/nrc1839","journal-title":"Nat Rev Cancer"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e318277608b","article-title":"Meta-analysis on the possible association between in vitro fertilization and cancer risk","volume":"23","author":"Li LL","year":"2013","unstructured":"Li LL, Zhou J, Qian XJ, Chen YD. Meta-analysis on the possible association between in vitro fertilization and cancer risk. Int J Gynecol Cancer. 2013, 23:16-24. 10.1097\/IGC.0b013e318277608b","journal-title":"Int J Gynecol Cancer"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt034","article-title":"IVF and breast cancer: a systematic review and meta-analysis","volume":"20","author":"Sergentanis TN","year":"2014","unstructured":"Sergentanis TN, Diamantaras AA, Perlepe C, Kanavidis P, Skalkidou A, Petridou ET. IVF and breast cancer: a systematic review and meta-analysis. Hum Reprod Update. 2014, 20:106-23. 10.1093\/humupd\/dmt034","journal-title":"Hum Reprod Update"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3328-0","article-title":"Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies","volume":"150","author":"Gennari A","year":"2015","unstructured":"Gennari A, Costa M, Puntoni M, et al.. Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies. Breast Cancer Res Treat. 2015, 150:405-13. 10.1007\/s10549-015-3328-0","journal-title":"Breast Cancer Res Treat"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa293","article-title":"Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis","volume":"36","author":"Barcroft JF","year":"2021","unstructured":"Barcroft JF, Galazis N, Jones BP, et al.. Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis. Hum Reprod. 2021, 36:1093-107. 10.1093\/humrep\/deaa293","journal-title":"Hum Reprod"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00313","article-title":"Do the fertility drugs increase the risk of cancer? A review study","volume":"10","author":"Momenimovahed Z","year":"2019","unstructured":"Momenimovahed Z, Taheri S, Tiznobaik A, Salehiniya H. Do the fertility drugs increase the risk of cancer? A review study. Front Endocrinol (Lausanne). 2019, 10:313. 10.3389\/fendo.2019.00313","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15155800","article-title":"Assisted reproductive technology in breast and gynecologic malignancies: cancer risk, fertility preservation, and post-treatment reproductive outcomes","volume":"15","author":"Cherouveim P","year":"2026","unstructured":"Cherouveim P, Cetin E, Sooknarine C, et al.. Assisted reproductive technology in breast and gynecologic malignancies: cancer risk, fertility preservation, and post-treatment reproductive outcomes. J Clin Med. 2026, 15:10.3390\/jcm15155800","journal-title":"J Clin Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.12.004","article-title":"BRCA mutations and reproduction","volume":"109","author":"Daum H","year":"2018","unstructured":"Daum H, Peretz T, Laufer N. BRCA mutations and reproduction. Fertil Steril. 2018, 109:33-8. 10.1016\/j.fertnstert.2017.12.004","journal-title":"Fertil Steril"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02880","article-title":"Association of germline BRCA pathogenic variants with diminished ovarian reserve: a meta-analysis of individual patient-level data","volume":"39","author":"Turan V","year":"2021","unstructured":"Turan V, Lambertini M, Lee DY, et al.. Association of germline BRCA pathogenic variants with diminished ovarian reserve: a meta-analysis of individual patient-level data. J Clin Oncol. 2021, 39:2016-24. 10.1200\/JCO.20.02880","journal-title":"J Clin Oncol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.986477","article-title":"Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis","volume":"13","author":"Liu X","year":"2022","unstructured":"Liu X, Yue J, Pervaiz R, Zhang H, Wang L. Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022, 13:986477. 10.3389\/fendo.2022.986477","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex027","article-title":"The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review","volume":"32","author":"Rodgers RJ","year":"2017","unstructured":"Rodgers RJ, Reid GD, Koch J, et al.. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Hum Reprod. 2017, 32:1033-45. 10.1093\/humrep\/dex027","journal-title":"Hum Reprod"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00535","article-title":"Pregnancy after breast cancer: a systematic review and meta-analysis","volume":"39","author":"Lambertini M","year":"2021","unstructured":"Lambertini M, Blondeaux E, Bruzzone M, et al.. Pregnancy after breast cancer: a systematic review and meta-analysis. J Clin Oncol. 2021, 39:3293-305. 10.1200\/JCO.21.00535","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501651-the-impact-of-assisted-reproduction-technology-on-breast-cancer-risk-for-women-with-infertility-current-insights-and-future-perspectives","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:30:52Z","timestamp":1789385452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501651-the-impact-of-assisted-reproduction-technology-on-breast-cancer-risk-for-women-with-infertility-current-insights-and-future-perspectives"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":58,"URL":"https:\/\/doi.org\/10.7759\/cureus.116210","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}